High numbers of CD163 tumor-associated macrophages correlate with poor prognosis in multiple myeloma patients receiving bortezomib-based regimens
High numbers of CD163 tumor-associated macrophages correlate with poor prognosis in multiple myeloma patients receiving bortezomib-based regimens
复制标题
在接受基于硼替佐米的治疗方案的多发性骨髓瘤患者中，大量 CD163 肿瘤相关巨噬细胞与不良预后相关
DOI：
10.7150/jca.30102
复制
发表时间：
2019
影响因子：
3.9
通讯作者：
Tang Hailin
中科院分区：
文献类型：
--
作者：
Wang Hua;Hu Wan ming;Xia Zhong jun;Liang Yang;Lu Yue;Lin Shu xia;Tang Hailin
